Follow
Share

My relative had a severe reaction to a new drug.

This question has been closed for answers. Ask a New Question.
Find Care & Housing
Is the drug FDA approved and on the market to be sold to everyone, or is the drug being given to someone in a controlled study whereby the person has consented to be in the study?
In the first case, the consumer is made aware of the possibility of being allergic to the med in the medication package insert. No one or company can guarantee an allergic reaction won’t occur as everyone reacts differently.
In case #2 and the person signed up for the study, I will almost bet that the person signed a consent to take the drug knowing there may be that chance.
Did the person identify & report their allergies to any medications? It is a shared responsibility for the provider to ask about existing allergies & the person’s responsibility to report personal allergies to their caregivers/pharmacy.
Can you clarify further? To predict how someone reacts to a new drug is not feasible. Some people as they get older develop allergies to meds they have taken in the past.
If you are referring to a patient in a nursing home or hospital that received a fairly new medication released by the FDA for general use or the med was just newly added to their medication regimen and the patient develops an allergic reaction, I don’t see how anyone can be faulted. Episodes like this occur. The medication management can’t predict it, but are required to observe for symptoms if they see them and then provide treatment - ie calling EMS, providing support until EMS gets there, Epipen use and documentation of intervention and noting the allergy in the patient’s medical records. 
Also if the patient is in a setting as mentioned above, the patient or their legal designee on admission sign a consent that permits the facility to treat the patient knowing that adverse reactions do occur. 
Helpful Answer (0)
Report

This question has been closed for answers. Ask a New Question.
Subscribe to
Our Newsletter